Stearoyl-CoA desaturase: A new therapeutic target of liver steatosis

Drug Development Research

Volumn 67, Issue 8, 2006, Pages 643-650

  Dobrzyn, Pawel ^a   Dobrzyn, Agnieszka ^b  

^a UNIVERSITY OF BIALYSTOK   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Atherosclerosis; Fatty acid oxidation; Fatty liver disease; Lipogenesis; Stearoyl co desaturase

Indexed keywords

ACYL COENZYME A DESATURASE; ESTER DERIVATIVE; ISOENZYME; LEPTIN; MONOUNSATURATED FATTY ACID; OLEIC ACID; PALMITOLEOATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOLIPID DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WAX;

ATHEROSCLEROSIS; DIET; ENERGY EXPENDITURE; ENZYME ACTIVITY; ENZYME MECHANISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY LIVER; FOOD INTAKE; HUMAN; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; METABOLIC REGULATION; MOUSE; MOUSE STRAIN; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PARTITION COEFFICIENT; PHENOTYPE; REVIEW; WEIGHT REDUCTION;

EID: 33845263672     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20139     Document Type: Review

References (54)

1. Agatha G, Hafer R, Zintl F. 2001. Fatty acid composition of lymphocyte membrane phospholipids in children with acute leukemia. Cancer Lett 173:139-144.
2. Angulo P. 2002. Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231.
3. Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, Poniachik J. 2004. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond) 106:635-643.
4. Asilmaz E, Cohen P, Miyazaki M, Dobrzyn P, Ueki K, Fayzikhodjaeva G, Soukas AA, Kahn CR, Ntambi JM, Socci ND, Friedman JM. 2004. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest 113:414-424.
5. Attie AD, Krauss RM, Gray-Keller MP, Brownlie A, Miyazaki M, Kastelein JJ, Lusis AJ, Stalenhoef AF, Stoehr JP, Hayden MR, Ntambi JM. 2002. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 43:1899-1907.
6. Beiraghi S, Zhou M, Talmadge CB, Went-Sumegi N, Davis JR, Huang D, Saal H, Seemayer TA, Sumegi J. 2003. Identification and characterization of a novel gene disrupted by a pericentric inversion inv(4)(p13.1q21.1) in a family with cleft lip. Gene 309:11-21.
7. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. 2000. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132:112-117.
8. Chen HC, Farese RV Jr. 2001. Turning WAT into BAT gets rid of fat. Nat Med 7:1102-1103.
9. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM. 2002. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297:240-243.
10. Dobrzyn A, Ntambi JM. 2004. The role of stearoyl-CoA desaturase in body weight regulation. Trends Cardiovasc Med 14:77-81.
11. Dobrzyn A, Ntambi JM. 2005a. The role of stearoyl-CoA desaturase in the control of metabolism. Prostaglandins Leukot Essent Fatty Acids 73:35-41.
12. Dobrzyn A, Ntambi JM. 2005b. Stearoyl-CoA desaturase as a new drug target for obesity treatment. Obes Rev 6:169-174.
13. Dobrzyn P, Dobrzyn A, Miyazaki M, Cohen P, Asilmaz E, Hardie DG, Friedman JM, Ntambi JM. 2004. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci USA 101:6409-6414.
14. Dobrzyn A, Dobrzyn P, Lee SH, Miyazaki M, Cohen P, Asilmaz E, Hardie DG, Friedman JM, Ntambi JM. 2005a. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by down-regulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. Am J Physiol Endocrinol Metab 288:E599-E607.
15. Dobrzyn A, Dobrzyn P, Miyazaki M, Ntambi JM. 2005b. Polyunsaturated fatty acids do not activate AMP-activated protein kinase in mouse tissues. Biochem Biophys Res Commun 332:892-896.
16. Dobrzyn A, Dobrzyn P, Miyazaki M, Sampath H, Chu K, Ntambi JM. 2005c. Stearoyl-CoA desaturase 1 deficiency increases CTP: choline cytidylyltransferase translocation into the membrane and enhances phosphatidylcholine synthesis in liver. J Biol Chem 280:23356-23362.
17. Enoch HG, Catala A, Strittmatter P. 1976. Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. J Biol Chem 251:5095-5103.
18. Estrada V, Serrano-Rios M, Martinez Larrad MT, Villar NG, Gonzalez Lopez A, Tellez MJ, Fernandez C. 2002. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy. J Acquir Immune Defic Syndr 29:32-40.
19. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. 2004. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 5:27-42.
20. Fromenty B, Robin MA, Igoudjil A, Mansouri A, Pessayre D. 2004. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 30:121-138.
21. Garg A. 2000. Lipodystrophies. Am J Med 108:143-152.
22. Guzman M, Lo Verme J, Fu J, Oveisi F, Blazquez C, Piomelli D. 2004. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J Biol Chem 279:27849-27854.
23. Hardie DG. 2004. The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci 117:5479-5487.
24. Jones BH, Maher MA, Banz WJ, Zemel MB, Whelan J, Smith PJ, Moustaid N. 1996. Adipose tissue stearoyl-CoA desaturase mRNA is increased by obesity and decreased by polyunsaturated fatty acids. Am J Physiol 271:E44-E49.
25. Kaestner KH, Ntambi JM, Kelly TJ Jr, Lane MD. 1989. Differentiation- induced gene expression in 3T3-L1 preadipocytes. A second differentially expressed gene encoding stearoyl-CoA desaturase. J Biol Chem 264:14755-14761.
26. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. 1999. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103:1489-1498.
27. Lee SH, Dobrzyn A, Dobrzyn P, Rahman SM, Miyazaki M, Ntambi JM. 2004. Lack of stearoyl-CoA desaturase 1 upregulates basal thermogenesis but causes hypothermia in a cold environment. J Lipid Res 45:1674-1682.
28. Lewis GF, Carpentier A, Adeli K, Giacca A. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23:201-229.
29. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, Schaffer JE. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 100:3077-3082.
30. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. 2001. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-1850.
31. Miyazaki M, Kim YC, Gray-Keller MP, Attie AD, Ntambi JM. 2000. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem 275:30132-30138.
32. Miyazaki M, Kim YC, Ntambi JM. 2001. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J Lipid Res 42:1018-1024.
33. Miyazaki M, Jacobson MJ, Man WC, Cohen P, Asilmaz E, Friedman JM, Ntambi JM. 2003. Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors. J Biol Chem 278:33904-33911.
34. Miyazaki M, Dobrzyn A, Man WC, Chu K, Sampath H, Kim HJ, Ntambi JM . 2004a. Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J Biol Chem 279:25164-25171.
35. Miyazaki M, Dobrzyn A, Sampath H, Lee SH, Man WC, Chu K, Peters JM, Gonzalez FJ, Ntambi JM. 2004b. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha. J Biol Chem 279:35017-35024.
36. Miyazaki M, Dobrzyn A, Elias PM, Ntambi JM. 2005. Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development. Proc Natl Acad Sci USA 102:12501-12506.
37. Nielsen MJ, Petersen G, Astrup A, Hansen HS. 2004. Food intake is inhibited by oral oleoylethanolamide, J Lipid Res 45:1027-1029.
38. Ntambi JM, Miyazaki M. 2004. Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res 43:91-104.
39. Ntambi JM, Buhrow SA, Kaestner KH, Christy RJ, Sibley E, Kelly TJ Jr, Lane MD. 1988. Differentiation-induced gene expression in 3T3-L1 preadipocytes. Characterization of a differentially expressed gene encoding stearoyl-CoA desaturase. J Biol Chem 263:17291-17300.
40. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM, Attie AD. 2002. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 99:11482-11486.
41. Ntambi JM, Miyazaki M, Dobrzyn A. 2004. Regulation of stearoyl-CoA desaturase expression. Lipids 39:1061-1065.
42. Pan DA, Hulbert AJ, Storlein LH. 1994. Dietary fats, membrane phospholipids and obesity. J Nutr 124:1555-1565.
43. Pettegrew JW, Panchalingam K, Hamilton RL, McClur RJ. 2001. Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 26:771-782.
44. Rahman SM, Dobrzyn A, Dobrzyn P, Lee SH, Miyazaki M, Ntambi JM. 2003. Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle. Proc Natl Acad Sci USA 100:11110-11115.
45. Reitman ML, Arioglu E, Gavrilova O, Taylor S. 2000. Lipoatrophy revisited. Trends Endocrinol Metab 11:410-416.
46. Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD. 1998. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 273:35299-35306.
47. Solans R, Motta C, Sola R, La Ville AE, Lima J, Simeon P, Montella N, Armadans-Gil L, Fonollosa V, Vilardell M. 2000. Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury. Arthritis Rheum 43:894-900.
48. Stals HK, Mannaerts GP, Declercq PE. 1992. Factors influencing triacylglycerol synthesis in permeabilized rat hepatocytes. Biochem J 283:719-725.
49. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW. 1991. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40:280-289.
50. Sun Y, Hao M, Luo Y, Liang CP, Silver DL, Cheng C, Maxfield FR, Tall AR. 2003. Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure. J Biol Chem 278:5813-5820.
51. Wahren J, Sato Y, Ostman J, Hagenfeldt L, Felig P. 1984. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise. J Clin Invest 73:1367-1376.
52. Zhang L, Ge L, Parimoo S, Stenn K, Prouty SM. 1999. Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites. Biochem J 340:255-264.
53. Zheng Y, Eilertsen KJ, Ge L, Zhang L, Sundberg JP Prouty SM, Stenn KS, Parimoo S. 1999. SCD1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat Genet 23:268-270.
54. Zheng Y, Prouty SM, Harmon A, Sundberg JP, Stenn KS, Parimoo S. 2001. Scd3: a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics 71:182-191.